Back
Xenon Pharmaceuticals 10K Form
Sell
38
XENE
Xenon Pharmaceuticals
Last Price:
$38.64
Seasonality Move:
18.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | XENE/Xenon Pharmaceuticals Quarterly |
| 2023-11-08 | 10Q | XENE/Xenon Pharmaceuticals Quarterly |
| 2023-08-09 | 10Q | XENE/Xenon Pharmaceuticals Quarterly |
| 2023-05-09 | 10Q | XENE/Xenon Pharmaceuticals Quarterly |
| 2022-11-08 | 10Q | XENE/Xenon Pharmaceuticals Quarterly |
| 2022-08-09 | 10Q | XENE/Xenon Pharmaceuticals Quarterly |
Receive XENE News And Ratings
See the #1 stock for the next 7 days that we like better than XENE
XENE Financial Statistics
Sales & Book Value
| Annual Sales: | $9.4M |
|---|---|
| Cash Flow: | $-51.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $10.53 |
| Price / Book: | 3.7 |
Profitability
| EPS (TTM): | -2.82000 |
|---|---|
| Net Income (TTM): | $-213.4M |
| Gross Margin: | $6.8M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Xenon Pharmaceuticals Earnings Forecast
Key Xenon Pharmaceuticals Financial Ratios
Xenon Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | XENE |
| CUSIP: | 98420N |
| Website: | xenon-pharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
XENE Technical Analysis vs Fundamental Analysis
Sell
38
Xenon Pharmaceuticals (XENE)
is a Sell
Is Xenon Pharmaceuticals a Buy or a Sell?
-
Xenon Pharmaceuticals stock is rated a SellThe current Xenon Pharmaceuticals [XENE] share price is $38.69. The Score for XENE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.